戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 estine alone, 75 liver and intestine, and 25 multivisceral.
2 small bowel/liver, 5.7% heart/lung, and 3.3% multivisceral.
3  bowel in nine, liver-bowel in five, and one multivisceral.
4 9, lung: 1, bone marrow: 1, liver-kidney: 1, multivisceral: 1).
5  intestine (24%), liver-intestine (62%), and multivisceral (14%).
6 were intestine (22%), liver/intestine (55%), multivisceral (16%), and modified multivisceral (7%).
7 ine (55%), multivisceral (16%), and modified multivisceral (7%).
8 aft rejection, but their role in small bowel/multivisceral allograft remains unclear.
9 the eight simultaneous LTx/KTx was part of a multivisceral allograft.
10 of organ-specific susceptibility to CR among multivisceral allografts with a tendency for the pancrea
11 f organ-specific susceptibility to ACR among multivisceral allografts with the small intestinal allog
12 o transplantation and achieve equity between multivisceral and liver-alone candidates on the liver tr
13 tacrolimus immunosuppression for intestinal, multivisceral, and liver transplantation.
14 ents received 24 grafts: 14 intestinal, nine multivisceral, and one liver-intestinal graft.
15 gans included isolated small bowel, modified multivisceral (bowel, pancreas, and stomach) and multivi
16 ivisceral (bowel, pancreas, and stomach) and multivisceral (bowel, pancreas, stomach, and liver).
17             Under current allocation policy, multivisceral candidates experience inferior waitlist ou
18 criptome of single cells derived from murine multivisceral CRC and delineated the intermetastatic cel
19 ng the cellular and molecular composition of multivisceral CRC metastasis in a sophisticated murine o
20 in the list for non-LT (heart, lung, kidney, multivisceral, etc.) it is mandatory to include the diag
21 re and liver autotransplantation (n = 8) and multivisceral ex vivo procedure (n = 7).
22                                              Multivisceral ex vivo surgery applying techniques of dec
23                  We performed three cases of multivisceral ex vivo surgery involving temporary remova
24 f guidance around submission and approval of multivisceral exception requests may help improve their
25                              Patients with a multivisceral graft experienced less episodes of severe
26 cessful procurement and transplantation of a multivisceral graft from a pediatric donor with polysple
27 ormed transplants of the spleen as part of a multivisceral graft in an attempt to decrease both the r
28                                          The multivisceral graft recipients were more likely to devel
29                            Younger children, multivisceral graft recipients, and particularly those w
30                    Our results show that the multivisceral graft seems to facilitate engraftment of t
31 llograft spleen can be transplanted within a multivisceral graft without significantly increasing the
32           The inclusion of the spleen in the multivisceral grafts tended to be at an increased risk o
33              We reviewed our experience with multivisceral grafts that included the entire pancreas.
34 e were no episodes of pancreatitis in the 44 multivisceral grafts which included a transplant pancrea
35 an era of severe organ shortage of pediatric multivisceral grafts, a valuable organ offer should not
36 ino children with gastroschisis who received multivisceral grafts.
37 lated bowel in two, liver-bowel in four, and multivisceral in nine (four with kidney).
38                                              Multivisceral left pancreatectomy is associated with wor
39 as the only risk factor for mortality in the multivisceral LP group.
40 he LP group and longer operative time in the multivisceral LP group.
41 ion in the LP group and ASA III or IV in the multivisceral LP group.
42                                              Multivisceral LP was associated with a higher rate of ma
43 ectomy as part of a multivisceral resection (multivisceral LP).
44  and worse overall outcomes after intestinal/multivisceral (MV) transplantation.
45 ine or liver-intestine (LI) (versus modified multivisceral [MV] or MV) allograft (P = 0.00003), alemt
46  receiving liver (OLTX), intestinal (ITX) or multivisceral (MVT) transplants.
47 tine (n = 28), liver and intestine (n = 27), multivisceral (n = 61), and multivisceral without the li
48 he 12 resuscitated grafts, two were used for multivisceral, one for a modified multivisceral, seven f
49 ACR and severe ACR: transplant type modified multivisceral or full multivisceral (P = 0.0009 and P <
50 ansplant type modified multivisceral or full multivisceral (P = 0.0009 and P < 0.000001), rATG/rituxi
51 retroperitoneal (P(interaction) = 0.84), and multivisceral (P(interaction) = 0.96) involvement.
52 5 centimeters (OR: 0.40, CI: 0.23-0.67), and multivisceral procedures (OR: 0.39, CI: 0.26-0.59).
53                                  All primary multivisceral recipients who received a donor spleen (N
54                              In 79 intestine/multivisceral recipients, sera were prospectively screen
55                                Recipients of multivisceral, redo, and lobar lung transplants and thos
56   Patients with RMP had much higher rates of multivisceral resection (40.4% vs 12.8%; relative risk,
57 m, P = 0.007) and were more often treated by multivisceral resection (LND: 47.8% vs no-LND: 18.1%; P
58 s underwent left pancreatectomy as part of a multivisceral resection (multivisceral LP).
59 een insufficiently studied in the context of multivisceral resection (MVR).
60 , TP with venous resection (type 2), TP with multivisceral resection (type 3), and TP with arterial r
61 ollected and the feasibility and efficacy of multivisceral resection for locally advanced clinical T4
62 orbidity and mortality rates, and an en bloc multivisceral resection should be performed in patients
63  the multivariable analysis, type 3 (TP with multivisceral resection) and type 4 (TP with arterial re
64 iate analysis adjusted for age, tumor stage, multivisceral resection, adjuvant treatment, and lymph n
65                                  The role of multivisceral resection, in the setting of locally advan
66 going left pancreatic resection as part of a multivisceral resection.
67 margin leads to high rates of conversion and multivisceral resection.
68 ections for tumor recurrences, including 121 multivisceral resections and 171 venous resections.
69  resection, including additional vascular or multivisceral resections, are rarely acknowledged when p
70 e used for multivisceral, one for a modified multivisceral, seven for liver-intestine, and two for is
71                             In this modified multivisceral technique, the native spleen and pancreas
72                               Candidates for multivisceral transplant (MVT) have experienced decrease
73 ITx as part of a combined liver-intestine or multivisceral transplant for a variety of indications, m
74 mporaneous parallel development of liver and multivisceral transplant models (Theme II).
75 lymphoma involving the intestinal graft of a multivisceral transplant patient.
76 homa affecting the intestinal allograft of a multivisceral transplant patient.
77        The Indiana University Intestinal and Multivisceral Transplant program experienced significant
78                           We report an adult multivisceral transplant recipient who experienced recur
79 s were taken from 4 isolated intestine and 3 multivisceral transplant recipients at the time of any o
80 LR-VRE infections among a group of liver and multivisceral transplant recipients in a single intensiv
81 plication of this technique in two pediatric multivisceral transplant recipients--one to buttress a l
82 ed from 111 consecutive pediatric intestinal/multivisceral transplant recipients: 2155 were obtained
83 s a 7-year-old girl who underwent at age 5 a multivisceral transplant secondary to short gut syndrome
84                                            A multivisceral transplant was performed.
85                                              Multivisceral transplant was protective with respect to
86 tion with the stronger predictor "receipt of multivisceral transplant" was controlled (P=0.23).
87  in the long term after pediatric intestinal/multivisceral transplant.
88                     Liver-sparing "modified" multivisceral transplantation (MMVTx) has recently been
89 of isolated intestinal transplantation (IIT)/multivisceral transplantation (MVT) are among those at t
90                                              Multivisceral transplantation (MVtx) involves simultaneo
91 t (SOT) group (n = 15; 12 ITX and 3 modified multivisceral transplantation [MMVTX]) and the SOT-AWTX
92 or combined liver-intestine transplantation (multivisceral transplantation [MVT]) remains unknown.
93                     This new modification of multivisceral transplantation allows pancreaticosplenic
94 ential complications after isolated bowel or multivisceral transplantation and long-term graft surviv
95               Small intestinal allografts in multivisceral transplantation are felt to be more suscep
96                      The patient underwent a multivisceral transplantation as a life-saving procedure
97 ysis of 98 consecutive patients who received multivisceral transplantation at our institution.
98                                              Multivisceral transplantation can be valuable for the tr
99                               Intestinal and multivisceral transplantation could be considered in pat
100                                              Multivisceral transplantation cured the patient's underl
101 ld woman with short bowel syndrome underwent multivisceral transplantation due to total parenteral nu
102                                   Intestinal/multivisceral transplantation enables a more radical app
103 only one report in the literature mentioning multivisceral transplantation for a patient with life-th
104 his is the first report in the literature of multivisceral transplantation for MMIHS.
105 nts the outcomes of 4 patients who underwent multivisceral transplantation from HCV-nucleic acid test
106                      A common requirement of multivisceral transplantation has been removal of the na
107                                              Multivisceral transplantation has recently evolved to be
108                Our case reports suggest that multivisceral transplantation is a valuable therapeutic
109 urgery applying techniques of deceased donor multivisceral transplantation is feasible in achieving l
110                                              Multivisceral transplantation is now an effective treatm
111 and contour in children undergoing bowel and multivisceral transplantation is often challenging due t
112 this study was to summarize the evolution of multivisceral transplantation over a decade of experienc
113                                          One multivisceral transplantation patient underwent isolated
114                In this cohort of small bowel/multivisceral transplantation patients, there was a high
115  3 isolated intestinal transplantation and 9 multivisceral transplantation patients.
116                              We believe that multivisceral transplantation should be considered as a
117                                              Multivisceral transplantation should be considered as a
118 ience with three patients with MMIHS in whom multivisceral transplantation was performed.
119         Early experience with intestinal and multivisceral transplantation was plagued with high risk
120                     In 2001, indications for multivisceral transplantation were expanded, and inducti
121 designed a new approach and have performed a multivisceral transplantation with splenopancreatic pres
122 l hemitransposition, portal arterialization, multivisceral transplantation) are associated with subop
123   Outcomes evaluated included need for liver/multivisceral transplantation, mortality, and the clinic
124 s (Tac) immunosuppression for intestinal and multivisceral transplantation.
125  unresponsive to all therapies, we performed multivisceral transplantation.
126          Three patients with MMIHS underwent multivisceral transplantation.
127 plantation and 7 patients underwent modified multivisceral transplantation.
128 hirty-seven patients underwent intestinal or multivisceral transplantation.
129 patients continue to be considered for liver/multivisceral transplantation.
130 with worse clinical outcomes after intestine/multivisceral transplantation.
131  sirolimus-associated PRES in the setting of multivisceral transplantation.
132 osure in both adults and pediatric liver and multivisceral transplantation.
133 15/11) obtained from recipients after SBT or multivisceral transplantation.
134 s now a common practice after intestinal and multivisceral transplantation.
135 . 25%, combined liver and SBTx=100% vs. 30%, multivisceral transplantation=25% vs. 50%.
136                                              Multivisceral transplanted patients experienced less epi
137             However, in a subset analysis of multivisceral transplanted patients since 2003, a favora
138  introduction of tacrolimus, small-bowel and multivisceral transplantion has increased to 100-200/yea
139 isolated intestinal transplants and modified multivisceral transplants (7 of 10, 70%).
140                     Forty-six intestinal and multivisceral transplants (MVtx) were performed between
141  age <18 years, ABO incompatibility, redo or multivisceral transplants, partial grafts, malignancies
142 x, 9 after liver-small bowel Tx, and 1 after multivisceral Tx.
143          In multivariable analysis, use of a multivisceral (with or without liver) transplant (P = 0.
144 estine (n = 27), multivisceral (n = 61), and multivisceral without the liver (n = 7).

 
Page Top